Trade Ideas October 9, 2026 09:10 AM

CNOB: Merger Scale and Improving Fundamentals Offer a Tactical Long Despite CRE Headwinds

A measured swing trade that leans on valuation, deal economics and cash flow while respecting commercial real estate risk.

By Marcus Reed
Share
Twitter Reddit Facebook LinkedIn
CNOB

ConnectOne Bancorp (CNOB) looks attractively priced at roughly $1.5B market cap with P/E ~9.9 and P/B ~0.93. The merger with The First of Long Island and solid free cash flow provide clear catalysts; commercial real estate exposure and macro sensitivity keep this a medium-risk tactical long over the next 45 trading days.

CNOB: Merger Scale and Improving Fundamentals Offer a Tactical Long Despite CRE Headwinds
CNOB
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Attractive headline valuation: P/E ~9.9 and P/B ~0.93 with market cap ~ $1.5B.
  • Merger with First of Long Island creates a larger franchise (~$14B assets) and potential cost/revenue synergies.
  • Free cash flow ~ $127.7M supports dividend and provides downside buffer.
  • Trade plan: Buy $30.00, Target $34.00, Stop $27.00, Mid term (45 trading days).

Hook & Thesis

ConnectOne Bancorp (CNOB) is a classic regional-bank setup where the macro and the specifics are giving investors a window to buy improved fundamentals at a reasonable multiple. The stock trades near $29.94 today, with a market capitalization around $1.5 billion, a P/E near 9.9 and a P/B below 1.0. Those are not numbers you see every day in a bank with positive ROE and meaningful free cash flow.

My trade idea: a tactical long on CNOB that captures the near-term benefits of merger scale, potential net interest margin expansion, and continued FCF conversion, while keeping a tight stop to manage commercial real estate (CRE) and macro risks. Entry $30.00, initial target $34.00, stop loss $27.00. The suggested horizon is mid term (45 trading days) to allow merger-related catalysts and any NIM tailwinds to play out.

What the company does and why the market should care

ConnectOne is a regional bank operating through ConnectOne Bank and a fintech arm, BoeFly. It underwrites commercial, CRE, commercial construction, residential real estate and consumer loans and focuses on New Jersey and surrounding markets. The approved merger with The First of Long Island Corporation (shareholder approval announced 02/14/2025) creates a combined franchise with roughly $14 billion in total assets and $11 billion in both deposits and loans - a scale step that matters for revenue diversification and funding cost flexibility.

Investors should care because banking is fundamentally a scale business: small differences in funding costs and loan yields can meaningfully lift EPS at this market cap. With EPS around $3.06 and market price implying a P/E below 10, the market is already pricing in some execution risk. If ConnectOne can deliver on margin expansion and integration synergies, the upside to $34+ is feasible without heroic assumptions.

Evidence the fundamentals are improving

  • Valuation looks supportive. Market cap sits near $1.5 billion. At the current price, P/E is ~9.9 and P/B about 0.93. Those multiples leave room for re-rating if ROE and margins move up modestly.
  • Profitability and cash flow. Reported EPS is $3.06 and free cash flow stands at $127.7 million. ROE is roughly 9.45% and ROA about 1.07% - not stellar, but respectable for a regional bank in the current rate environment.
  • Capital structure is conservative. Debt-to-equity is about 0.56 and the bank shows healthy liquidity ratios (current and quick at 2.25). Enterprise value is about $2.398 billion with EV/EBITDA ~10.5 and EV/Sales ~3.03.
  • Dividend income cushion. The dividend yields roughly 2.5-2.8% depending on which snapshot you use, giving yield-oriented investors some downside cushioning while waiting for catalysts.

Valuation framing

On a headline basis CNOB is cheap relative to a normalized earnings stream: P/E ~9.9 and P/B <1.0 imply the market expects subpar return conversion or credit stress ahead. That skepticism is at least partially warranted across the sector given CRE concerns, but the numbers also signal an opportunity: a modest recovery in margins or a successful integration of the First of Long Island deal could re-rate the stock meaningfully. With free cash flow near $128 million on enterprise value ~$2.4 billion, the FCF yield is non-trivial and supports a case for upside without assuming outsized multiple expansion.

Key catalysts

  • Merger integration: The shareholder-approved deal (02/14/2025) should deliver scale economics and deposit-cost improvements over the next quarters; realized synergies would be a clear re-rating catalyst.
  • Net interest margin (NIM) expansion: Even small improvements in loan yields or lower funding costs can flow directly to EPS given the bank's leverage and the size of its loan book.
  • Pre-provision profitability and cost control: Continued FCF generation and expense discipline would ease valuation concerns tied to credit risk.
  • Dividend continuity: Management has been paying a quarterly common dividend ($0.195 per share), which helps support the share price in down markets and attracts income buyers.

Trade plan (actionable)

Entry: $30.00
Stop loss: $27.00
Target: $34.00
Direction: Long
Horizon: Mid term (45 trading days)

Rationale: Use $30.00 as a pragmatic entry near current levels to capture upside from merger-related execution, potential NIM improvement, and continued FCF conversion. The stop at $27.00 limits downside to a level that would indicate either a re-acceleration in CRE concerns or a broader regional-bank selloff overwhelming idiosyncratic positives. Target $34.00 sits just below the 52-week high of $34.14 and is achievable if market sentiment stabilizes and the market gives credit for integration and margin progress within the next 45 trading days.

Alternative timeframes

  • Short term (10 trading days): A quick mean-reversion trade could be run with a tighter stop ($29.00) if you expect immediate technical bounce off oversold indicators (RSI ~36). This is higher risk given macro headlines can swing regional banks sharply.
  • Long term (180 trading days): Owners focused on the full merger payoff and franchise growth can hold through the cycle, but should reassess after reported integration metrics and CRE charge developments.

Technical & market context

Technically, CNOB is off its 50-day and 20-day moving averages (SMA 50 ~$31.77, SMA 20 ~$30.83) and shows bearish momentum (MACD slightly negative, RSI ~36). Average daily volume sits in the mid-hundreds of thousands, so the stock can absorb medium-sized orders without extreme slippage. Short interest runs in the low millions (recent settlement near 1.82M), suggesting a modest short base that could amplify moves if sentiment flips.

Risks and counterarguments

  • CRE exposure: The sector-wide worries about commercial real estate remain the single biggest risk. If credit metrics deteriorate materially, CNOB’s earnings and book value could take a hit and invalidate the thesis.
  • Integration execution: Mergers often produce cost overruns or delayed revenue synergies. If the combined company fails to deliver expected savings, the stock may remain depressed.
  • Rate environment volatility: Unexpected Fed moves or a rapid drop in short-term rates could compress NIM if deposit re-pricing dynamics change unfavorably.
  • Macro or regional banking shocks: A renewed risk-off episode affecting regional banks could force multiple compression even if CNOB’s fundamentals hold steady.
  • Liquidity & trading risk: Average volume is several hundred thousand shares; in stressed markets the stock could gap, producing slippage through the intended stop.

Counterargument

One reasonable counterargument is that the market is rightly discounting CNOB because CRE concerns are underappreciated at current prices. If the bank's CRE concentration is higher than peers or if reserves prove insufficient, then a valuation multiple below 10 and P/B under 1 reflect prudent skepticism. That is why the trade uses a tight stop and a relatively short mid-term horizon to avoid being caught in a prolonged CRE downturn.

Conclusion - stance and what would change my mind

My stance: tactically long CNOB with clearly defined risk controls. The combination of attractive headline valuation (P/E ~9.9, P/B ~0.93), strong free cash flow conversion (~$128 million), and merger-driven scale make this a buyable setup for a mid-term trade. The trade balances upside from operational improvements and re-rating against structural CRE risk by using a $27 stop.

I would change my view if any of the following occur: (1) management discloses material deterioration in CRE loan performance or sizable reserve shortfalls; (2) integration updates show significant missed synergies or unexpected dilution from the merger; or (3) the broader regional-banking stress intensifies and drags valuation multiples lower across the cohort. Absent those outcomes, the combination of yield, cash flow, and reasonable multiples supports a 45-trading-day tactical long.

Trade summary: Buy CNOB at $30.00, target $34.00, stop $27.00. Mid-term horizon: 45 trading days—watch merger integration and CRE credit trends closely.

Note: Dividend dates include an ex-dividend of 08/14/2026 and payable date 09/01/2026; these provide modest income while the trade develops.

Risks

  • Commercial real estate exposure could trigger credit losses and pressure book value.
  • Merger integration may miss synergies or incur unexpected costs.
  • Interest-rate volatility could compress NIM and earnings unexpectedly.
  • Broader regional banking stress or risk-off selling could force multiple compression beyond fundamentals.

More from Trade Ideas

Lowe's: Buy the Dip — Weak Housing, Strong Cash Flow, Compelling Entry Oct 9, 2026 Zeta: AI Momentum and Margin Leverage Create a Tactical Long Opportunity Oct 9, 2026 Galiano Gold: Short-Term Pullback Trade While the Growth Thesis Holds Oct 9, 2026 Grab’s Financial Services Push: Why Atome and GrabFin Could Re-rate GRAB — A Long Trade Plan Oct 9, 2026 Drink Up: Why Coca-Cola ($KO) Still Deserves a Place in a Patient Portfolio Oct 9, 2026